Cardinal Health (NYSE:CAH) Price Target Raised to $115.00 at Evercore ISI

Cardinal Health (NYSE:CAH) had its price target lifted by investment analysts at Evercore ISI from $110.00 to $115.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has an “in-line” rating on the stock. Evercore ISI’s target price suggests a potential upside of 16.28% from the stock’s current price.

A number of other research analysts have also issued reports on CAH. StockNews.com upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Thursday. SVB Leerink assumed coverage on Cardinal Health in a research report on Monday, February 26th. They set an “outperform” rating and a $125.00 price objective for the company. Argus raised Cardinal Health from a “hold” rating to a “buy” rating in a research report on Friday, February 9th. UBS Group increased their price objective on Cardinal Health from $122.00 to $125.00 and gave the company a “buy” rating in a research report on Monday, February 5th. Finally, Robert W. Baird cut their target price on shares of Cardinal Health from $134.00 to $128.00 and set an “outperform” rating for the company in a research note on Friday. One analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $105.79.

Cardinal Health Trading Down 4.0 %

NYSE CAH traded down $4.08 during trading on Friday, hitting $98.90. 3,445,729 shares of the company traded hands, compared to its average volume of 2,288,769. Cardinal Health has a 12 month low of $77.56 and a 12 month high of $116.04. The business has a fifty day simple moving average of $109.28 and a 200 day simple moving average of $104.97. The company has a market capitalization of $24.06 billion, a P/E ratio of 38.95, a PEG ratio of 1.03 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, May 2nd. The company reported $2.08 earnings per share for the quarter, beating analysts’ consensus estimates of $1.95 by $0.13. The business had revenue of $54.90 billion for the quarter, compared to the consensus estimate of $56.05 billion. Cardinal Health had a negative return on equity of 57.44% and a net margin of 0.30%. The firm’s revenue was up 8.7% compared to the same quarter last year. During the same period last year, the business earned $1.74 EPS. Equities research analysts predict that Cardinal Health will post 7.28 EPS for the current fiscal year.

Institutional Investors Weigh In On Cardinal Health

Several large investors have recently modified their holdings of the stock. Norges Bank bought a new stake in Cardinal Health in the fourth quarter valued at $258,499,000. Ameriprise Financial Inc. increased its position in shares of Cardinal Health by 82.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 4,128,009 shares of the company’s stock worth $358,390,000 after purchasing an additional 1,862,291 shares in the last quarter. California Public Employees Retirement System lifted its holdings in Cardinal Health by 118.9% during the 4th quarter. California Public Employees Retirement System now owns 1,516,035 shares of the company’s stock valued at $152,816,000 after purchasing an additional 823,520 shares during the last quarter. International Assets Investment Management LLC acquired a new position in Cardinal Health in the fourth quarter valued at about $464,800,000. Finally, CIBC Private Wealth Group LLC grew its stake in Cardinal Health by 1,941.9% during the fourth quarter. CIBC Private Wealth Group LLC now owns 458,160 shares of the company’s stock worth $46,183,000 after buying an additional 435,722 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.